According to research by the World Health Organization (WHO) on prostate cancer, diet and certain genetic factors are some of the major risk factors for prostate cancer among men above 45 years of age. Prostate cancer is a serious health issue and the most common cause of cancer-related deaths among men after lung cancer. In several developed regions, it is the most common cancer diagnosed, while in less developed regions it is also among the most common cancers diagnosed among men.
Browse the full Global Prostate Cancer Minimally Invasive Surgery Market Report: http://www.mrrse.com/prostat-cancer-minimal-invasive-surgery-market
Globally, more than 1.9 million people were diagnosed with prostate cancer in 2010, according to leading market experts in a recent study on the prostate cancer market. Moreover, the highest number of people suffering from prostate cancer are found in regions such as Africa and the U.S., where heredity, old age, and increasing preference to harmful lifestyle habits such as smoking and a diet rich in red meat and fat are the critical factors increasing the risk of prostate cancer in men.
All the above factors have stimulated great awareness among people regarding the acceptance of prostate-specific antigen (PSA) tests and androgen-deprivation therapy (ADT), as well as the availability of several types of minimally invasive prostate cancer surgeries and specific surgical devices in the global market.
Benefits of Surgery over Conventional Treatment Regimen for Aggressive Prostate Cancer
For decades, the most preferred treatment for prostate cancer was a combination of hormone and radiation therapy. However, over the years, surgical treatment for aggressive prostate cancer has shown better results in terms of patient morbidity, convenience, and safety. Due to these benefits, surgical treatments are highly preferred over traditional radiation therapy. Among surgical treatments, minimally invasive surgeries are highly in demand.
Although slow-growing cancers sometimes take years to cause serious problems to the body, high-risk cancer types such as prostate cancer have the potential to quickly metastasize to other parts of the body. Often, emotions such as anxiety or intimidation further fuel the spread of cancer, thus leading to a higher chance of death. Hence, early diagnosis, routine and timely screening, various treatment procedures, and mind-relaxing therapies are key life-changing options in such cases. Awareness of the same has tremendously increased the survival rate of prostate cancer patients in the world.
Focus of the Market is on Robotic Prostate Surgery
Surgical robots are the most critical innovation in today’s times and have revolutionized the prostate cancer minimally invasive surgery market drastically. As many surgeons learn about and adopt minimally invasive surgery techniques and related devices, the uptake of robotic surgery has led to major changes during complex operations. Surgical robots offer better control over surgeries and less risk of side effects such as impotency in the long run. These devices are widely being adopted in hospital settings despite their high costs.
Most prostate cancer patients who undergo robotic surgery are discharged after two or three days after the surgery. They even experience less bleeding and pain due to the benefits of the small surgical incisions. The new improved techniques of robotic surgery have also helped patients recover completely from urinary problems within three to four months.
Browse the full Press Release of Global Prostate Cancer Minimally Invasive Surgery Market : http://www.mrrse.com/prostat-cancer-minimal-invasive-surgery-industry